Upon activation, PD-1 expression in T cells is significantly upregulated and delivers inhibitory signals via binding to PD-1 ligands (PD-L1 and PD-L2) expressed by APCs or cancer cells [143], leading to dampened immune responses. Here, PDCD1 is linked to cancer.